Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

United States第117届国会HRES-1434House of Representatives
更新于：2022年12月22日

摘要

暂无摘要。

法案文本

可用版本
查看官方文本

有 2 个可用版本

已显示全部可用记录。

时间线

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Passed/agreed to in House: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

  4. Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

    House of Representatives